Description

5-Amino-1MQ 50MG

We provide 5-Amino-1MQ as a small-molecule research compound in a 50MG vial with a stated 99.1% purity. Furthermore, this compound has become an important research tool for studying nicotinamide N-methyltransferase (NNMT), an enzyme that connects nicotinamide metabolism with the NAD+ salvage pathway and methionine metabolism. Consequently, researchers use 5-Amino-1MQ to investigate how NNMT activity influences intracellular NAD+, S-adenosylmethionine (SAM), 1-methylnicotinamide (1-MNA), and cellular energy regulation.

Key Attributes

• Brand: AvigenLab
• Product Name: 5-Amino-1MQ
• Quantity: 50MG
• Stated Purity: 99.1%
• Molecular Type: Small-Molecule NNMT Inhibitor
• Target Enzyme: Nicotinamide N-Methyltransferase (NNMT)
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

5-Amino-1MQ Product Overview

We provide 5-Amino-1MQ for research involving metabolic regulation, NAD+ metabolism, methionine-cycle biology, adipocyte metabolism, and cellular energy homeostasis. Moreover, NNMT catalyzes the methylation of nicotinamide using SAM, producing 1-MNA and S-adenosylhomocysteine (SAH). Therefore, inhibiting this enzyme provides researchers with a useful approach for examining how these interconnected metabolic pathways respond to reduced NNMT activity.

Additionally, experimental studies have shown that NNMT inhibition with 5-amino-1MQ can reduce intracellular 1-MNA while increasing intracellular NAD+ and SAM in cultured adipocytes. Consequently, researchers continue to examine NNMT inhibition as a mechanism for understanding metabolic and energy-regulation pathways.

You can explore additional research materials through our Online Store.

5-Amino-1MQ Product Identification

We identify 5-Amino-1MQ as a 50MG research compound with a stated 99.1% purity. Furthermore, scientific literature identifies 5-amino-1MQ as a membrane-permeable small-molecule NNMT inhibitor that interacts with the nicotinamide-binding site of NNMT.

Accordingly, its primary research identity comes from its ability to modulate NNMT activity rather than from a peptide sequence or protein structure.

Product Category

We classify 5-Amino-1MQ within our small-molecule metabolic research collection. Accordingly, its research relevance extends across NAD+ salvage, methionine metabolism, SAM regulation, adipocyte biology, lipid metabolism, and cellular energy homeostasis.

Moreover, NNMT represents a metabolic control point because its activity consumes nicotinamide and SAM while generating 1-MNA. Therefore, researchers can use selective NNMT inhibition to examine how changes at this enzymatic step influence interconnected metabolic pathways.

Scientific Characteristics

5-Amino-1MQ functions as an NNMT inhibitor rather than a peptide or naturally occurring protein. In particular, research characterizes it as a small molecule that competes at the nicotinamide-binding site of NNMT. Consequently, its experimental value comes from targeted modulation of NNMT-dependent metabolism.

Furthermore, NNMT normally transfers a methyl group from SAM to nicotinamide, producing 1-MNA. By inhibiting this reaction, 5-Amino-1MQ can alter the intracellular availability of metabolites connected with both the NAD+ salvage pathway and methionine cycle.

Research Applications

We position 5-Amino-1MQ for research involving NNMT biology, NAD+ salvage, SAM metabolism, adipocyte differentiation, lipogenesis, metabolic signaling, and cellular energy homeostasis.

Additionally, laboratory studies have reported that 5-amino-1MQ reduces intracellular 1-MNA and increases intracellular NAD+ and SAM in adipocytes. Moreover, those studies observed suppression of lipid accumulation in differentiating adipocytes, providing a research basis for examining NNMT’s relationship with lipogenesis.

Likewise, animal research has investigated NNMT inhibition in diet-induced obesity models. However, these findings represent preclinical research and should remain within their experimental context rather than being presented as established human outcomes.

Product Configuration

We provide 5-Amino-1MQ in a 50MG vial with a stated 99.1% purity. Therefore, the quantity and purity designation provide clear reference points for laboratory inventory, analytical documentation, and research-material organization.

Moreover, the vial configuration distinguishes this presentation from other quantities or formulations. Consequently, researchers can identify the material consistently through its product name, quantity, purity, physical format, and research classification.

Product Features

The primary product features include a 50MG quantity, 99.1% stated purity, and a clearly defined research-use presentation. Additionally, the compound’s established NNMT activity gives researchers a specific molecular target for metabolic pathway studies.

Furthermore, published research has reported selective inhibition of NNMT without significant inhibition of several related methyltransferases or enzymes involved in the NAD+ salvage pathway under the tested experimental conditions. Nevertheless, selectivity can depend on experimental concentration and assay conditions, so researchers should interpret such findings within the specific study design.

Product Specifications

Intended Research Context

We identify 5-Amino-1MQ as Research Use Only and Not For Human Use. Accordingly, our product documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can investigate NNMT inhibition within experimental systems examining NAD+ metabolism, SAM availability, 1-MNA production, adipocyte biology, lipid accumulation, and metabolic signaling. Moreover, recent research continues to evaluate NNMT inhibition across cellular and animal models while exploring its broader metabolic mechanisms.

Packaging Information

We present 5-Amino-1MQ in a clearly labeled 50MG vial featuring our AvigenLab product presentation. The packaging identifies the compound, displays the 50MG quantity, and communicates the stated 99.1% Purity designation.

Additionally, the label communicates Not For Human Use | Research Use Only. Therefore, the packaging provides straightforward product identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify 5-Amino-1MQ as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific studies involving NNMT inhibition do not constitute regulatory approval for a specific product.

Nevertheless, the compound has a well-established presence in experimental research investigating NNMT and metabolic regulation. Therefore, we focus our documentation on its molecular characteristics, research applications, and experimentally established mechanisms rather than making unsupported clinical claims.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because small-molecule stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent handling while avoiding assumptions about conditions that may vary between formulations.

Market Availability

Our 5-Amino-1MQ 50MG provides a defined small-molecule research configuration within our product collection. The product name, 50MG quantity, 99.1% purity designation, vial format, and research classification create clear reference points for laboratory inventory.

Moreover, its established role as an NNMT research inhibitor makes the compound relevant to studies examining NAD+ metabolism, SAM regulation, adipocyte biology, and broader metabolic homeostasis. Accordingly, researchers can distinguish this material from peptide-based research compounds through its small-molecule structure and enzymatic target.

Product Reference

Our product is a small-molecule NNMT inhibitor presented in a 50MG vial with a stated 99.1% purity designation. We document the compound according to its defined molecular identity, NNMT-targeting activity, metabolic research relevance, product configuration, and Research Use Only classification.

Consequently, Our product provides researchers with a defined molecular tool for investigating NNMT-dependent metabolism and its connections with NAD+ salvage, SAM availability, 1-MNA production, adipocyte lipogenesis, and cellular energy regulation. Research continues to examine these pathways across cellular and animal models, while current evidence remains primarily experimental and preclinical.